{"content":"<li class=\"n-box-item date-title\" data-end=\"1448081999\" data-start=\"1447995600\" data-txt=\"Sunday, December 22, 2019\">Friday, November 20, 2015</li><li class=\"n-box-item sa-box-item\" data-id=\"2945486\" data-ts=\"1448068407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGF.A\" target=\"_blank\">LGF.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2945486-mockingjay-to-make-splash-raise-questions-for-lions-gate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Mockingjay&#39; to make splash, but raise questions for Lions Gate</a></h4><ul>   <li>\n<i>The Hunger Games: Mockingjay Part 2</i> should easily dominate film competition this weekend, though expectations for an opening of $110M-$125M would put it <a href=\"http://variety.com/2015/film/news/box-office-mockingjay-2-hunger-games-night-beforellion-weekend-in-u-s-1201645714/\" target=\"_blank\">below the franchise's average</a> (closer to $144M openings), if still one of the top weekends of the year.</li>    <li>With the closing of this chapter, though, the question for Lions Gate (LGF <font color=\"red\">-3.3%</font>) becomes: What happens after Katniss?</li>    <li>The studio has <a href=\"http://www.bloomberg.com/news/articles/2015-11-19/lions-gate-braces-for-life-after-hunger-games\" target=\"_blank\">made bones</a> in recent years with the young-adult novel-adaptation market, from the <i>Twilight</i> series ($3.34B worldwide) through <i>The Hunger Games</i> ($2.3B so far) to the <i>Divergent</i> films ($586M so far). Beyond that, though, there's no obvious replacement in the wings.</li>    <li>There's still a third and fourth <i>Divergent</i> film in a sequel-heavy slate ahead for Lions Gate. \u201cThey\u2019ve made a lot of money from the <i>Hunger Games</i> franchise, but that profit largely comes to an end next year,\u201d says Cowen's Doug Creutz, and \u201cthere are only more competitors trying to do the same as Lions Gate.\u201d</li>    <li>B. Riley's Eric Wold points to the studio's track record with strong material, though: \u201cManagement believes that Lions Gate is still the first destination for authors with new storylines ... And we believe that as long as there are young adults seeing movies, there will be an audience for young adult films.\u201d</li>    <li>Meanwhile, the studio is licensing the <i>Hunger Games</i> name for theme park attractions in Dubai, Atlanta and China, and \"It's pretty clear there is a prequel ... on the horizon,\" says Wold.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2945486\" data-linked=\"&#39;Mockingjay&#39; to make splash, but raise questions for Lions Gate\" data-tweet=\"$LGF.A - &#39;Mockingjay&#39; to make splash, but raise questions for Lions Gate https://seekingalpha.com/news/2945486-mockingjay-to-make-splash-raise-questions-for-lions-gate?source=tweet\" data-url=\"https://seekingalpha.com/news/2945486-mockingjay-to-make-splash-raise-questions-for-lions-gate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2945476\" data-ts=\"1448067022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2945476-analysts-t-mobiles-video-moves-build-customers-yet-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts: T-Mobile&#39;s video moves could build customers yet again</a></h4><ul>   <li>Strategy Analytics is pointing to T-Mobile's (<a href=\"https://seekingalpha.com/symbol/TMUS\" title=\"T-Mobile US, Inc.\">TMUS</a> <font color=\"green\">+1.9%</font>) moves to steal more customers with its latest \"Un-carrier\" moves toward video streaming and bigger data buckets as <a href=\"http://www.wirelessweek.com/news/2015/11/report-un-carrier-set-binge-holiday-net-adds\" target=\"_blank\">likely to bear fruit</a> in the holiday quarter.</li>    <li>By exempting video streaming from its data caps, the carrier is making a big early entrance in the next big battleground for the big four, Nitesh Patel writes, with the plan \"removing consumers\u2019 concern about blowing their data allowance or incurring competitors\u2019 huge overage fees.\"</li>    <li>Meanwhile, don't overlook its network, says Strategy Analytics' Susan Welsh de Grimaldo; while Sprint talks up its network improvements, T-Mobile has made major improvements as it builds out 700 MHz spectrum.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2945476\" data-linked=\"Analysts: T-Mobile&#39;s video moves could build customers yet again\" data-tweet=\"$TMUS - Analysts: T-Mobile&#39;s video moves could build customers yet again https://seekingalpha.com/news/2945476-analysts-t-mobiles-video-moves-build-customers-yet-again?source=tweet\" data-url=\"https://seekingalpha.com/news/2945476-analysts-t-mobiles-video-moves-build-customers-yet-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2945456\" data-ts=\"1448065286\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWX\" target=\"_blank\">TWX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2945456-study-hbo-in-demand-netflix-thrones-margin\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Study: HBO more in &#39;demand&#39; than Netflix, by a &#39;Thrones&#39; margin</a></h4><ul>   <li>A new study tries to <a href=\"http://www.broadcastingcable.com/news/programming/study-more-demand-hbo-netflix/145969\" target=\"_blank\">pierce the veil</a> over Netflix's \"ratings\" in comparison to its peers, and finds them wanting compared to HBO (<a href=\"https://seekingalpha.com/symbol/TWX\" title=\"Time Warner Inc.\">TWX</a> <font color=\"red\">-0.4%</font>) -- though likely due to one big series.</li>    <li>Parrot Analytics has studied what it calls \"demand expressions\" to compare original and flagship shows at Netflix (<a href=\"https://seekingalpha.com/symbol/NFLX\" title=\"Netflix, Inc.\">NFLX</a> <font color=\"green\">+3%</font>), HBO and Amazon.com. The metric includes a number of factors, including video streaming, social media, blogging, file-sharing and wiki platforms.</li>    <li>HBO and Netflix held all the top 10 spots for September in Parrot's analysis: <i>Game of Thrones</i> on top with 28.2M expressions, with Netflix's <i>Narcos</i> second at 14.3M. Meanwhile, Amazon shows held spots 11-15.</li>    <li>Rounding out the top five were Netflix's <i>Orange is the New Black</i> (nearly 8M expressions), HBO's <i>True Detective</i> (7.8M) and HBO's <i>Silicon Valley</i> (6.3M).</li>    <li>But take <i>Game of Thrones</i> out of the measurements, Parrot says, and HBO and Netflix have virtually the same demand.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2945456\" data-linked=\"Study: HBO more in &#39;demand&#39; than Netflix, by a &#39;Thrones&#39; margin\" data-tweet=\"$TWX $TWX $NFLX - Study: HBO more in &#39;demand&#39; than Netflix, by a &#39;Thrones&#39; margin https://seekingalpha.com/news/2945456-study-hbo-in-demand-netflix-thrones-margin?source=tweet\" data-url=\"https://seekingalpha.com/news/2945456-study-hbo-in-demand-netflix-thrones-margin\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2945426\" data-ts=\"1448063335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERB\" target=\"_blank\">ERB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2945426-erba-diagnostics-says-previous-financials-cant-be-relied-upon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ERBA Diagnostics says previous financials can&#39;t be relied upon</a></h4><ul>   <li>ERBA Diagnostics (<a href=\"https://seekingalpha.com/symbol/ERB\" title=\"ERBA Diagnostics, Inc.\">ERB</a> <font color=\"red\">-1.7%</font>) says its audit committee has determined that its financial statements for the years ended Dec. 31, 2014 and 2013 and the first two quarters of this year can't be relied upon.</li>    <li>It says early indications are that adjustments will result in an aggregate decrease in net income by $3M-$4M as well as a shift in timing of income and expense items, which will \"materially impact cost of goods sold, general and administrative expense and various off-setting balance sheet accounts.\"</li>    <li>ERBA is planning to restate all the \"non-reliance periods\" as soon as practicable.</li>    <li>Earlier, ERBA had said it would delay its 10-Q for the quarter ended Sept. 30, and it will file those financials along with the restated results.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2945426\" data-linked=\"ERBA Diagnostics says previous financials can&#39;t be relied upon\" data-tweet=\"$ERB - ERBA Diagnostics says previous financials can&#39;t be relied upon https://seekingalpha.com/news/2945426-erba-diagnostics-says-previous-financials-cant-be-relied-upon?source=tweet\" data-url=\"https://seekingalpha.com/news/2945426-erba-diagnostics-says-previous-financials-cant-be-relied-upon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2945376\" data-ts=\"1448059273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCR\" target=\"_blank\">NVCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2945376-novocureplus-21-ah-on-promising-results-for-ttf-brain-cancer-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novocure +21% AH on promising results for TTF brain cancer treatment</a></h4><ul>\n<li>Novocure (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NVCR\" title=\"NovoCure\">NVCR</a>) <font color=\"green\">+20.7%</font> AH after announcing that brain cancer patients lived significantly longer when treated with  its Tumor Treating Fields therapy than patients who  received chemotherapy alone.</li>\n<li>Brain cancer patients in a late stage clinical trial treated with  NVCR's Optune along with Roche's Avastin using TTF therapy had a 39%  reduced death risk compared with patients taking Avastin alone, the  company says.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2945376\" data-linked=\"Novocure +21% AH on promising results for TTF brain cancer treatment\" data-tweet=\"$NVCR - Novocure +21% AH on promising results for TTF brain cancer treatment https://seekingalpha.com/news/2945376-novocureplus-21-ah-on-promising-results-for-ttf-brain-cancer-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/2945376-novocureplus-21-ah-on-promising-results-for-ttf-brain-cancer-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2945356\" data-ts=\"1448059133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2945356-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/NVCR' title='NovoCure'>NVCR</a> <font color='green'>+18.0%</font>. <a href='https://seekingalpha.com/symbol/CLLS' title='Cellectis S.A.'>CLLS</a> <font color='green'>+4.3%</font>. <a href='https://seekingalpha.com/symbol/E' title='ENI S.p.A.'>E</a> <font color='green'>+3.3%</font>. KBIO <font color='green'>+2.2%</font>. <a href='https://seekingalpha.com/symbol/CS' title='Credit Suisse Group AG'>CS</a> <font color='green'>+2.2%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/NYMT' title='New York Mortgage Trust, Inc.'>NYMT</a> <font color='red'>-1.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2945356\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$NVCR $CLLS $E - After Hours Gainers / Losers https://seekingalpha.com/news/2945356-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2945356-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2945306\" data-ts=\"1448057558\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TKPHF\" target=\"_blank\">TKPHF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2945306-takeda-wins-fda-approval-for-multiple-myeloma-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Takeda wins FDA approval for multiple myeloma treatment</a></h4><ul>   <li>Takeda Pharmaceutical (<a href=\"https://seekingalpha.com/symbol/TKPYY\" target=\"_blank\">TKPYY</a> <font color=\"green\">+1.8%</font>) says the FDA has approved its drug Ninlaro (ixazomib) for use in patients with multiple myeloma who received at least one prior therapy.</li>    <li>The approval is based on the TOURMALINE-MM1 Phase 3 trial. Ninlaro is the only oral proteasome inhibitor, delivered via a once-weekly pill.</li>    <li>\"With the approval of Ninlaro, we can now offer patients a once-weekly oral proteasome inhibitor as part of a highly active triplet therapy,\" said Takeda's Paul Richardson, investigator for the trial. \"This opens the door for a fully oral proteasome inhibitor-based triplet combination therapy,\" said Dr. Brian Durie, chairman of the International Myeloma Foundation.</li>    <li>Takeda ADRs were <font color=\"green\">up 0.5%</font> after hours earlier.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2945306\" data-linked=\"Takeda wins FDA approval for multiple myeloma treatment\" data-tweet=\"$TKPHF $TAK - Takeda wins FDA approval for multiple myeloma treatment https://seekingalpha.com/news/2945306-takeda-wins-fda-approval-for-multiple-myeloma-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/2945306-takeda-wins-fda-approval-for-multiple-myeloma-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2945236\" data-ts=\"1448055927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMBL\" target=\"_blank\">NMBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2945236-nimble-slammed-11-downgrades-due-to-earnings-guidance-shares-close-down-50_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nimble slammed with 11 downgrades due to earnings/guidance; shares close down 50.7%</a></h4><ul>\n<li>Barclays, Monness Crespi, Oppenheimer, Pac Crest, Raymond James, RBC, Stifel, UBS, Wells Fargo, William Blair, and Wunderlich all downgraded Nimble Storage (NYSE:<a href=\"https://seekingalpha.com/symbol/NMBL\" title=\"Nimble Storage, Inc.\">NMBL</a>) to neutral ratings in response to the company's <a href=\"https://seekingalpha.com/news/2942326-nimble-storage-misses-by-0_06-misses-on-revenue\" target=\"_blank\">FQ3 miss</a> and <a href=\"https://seekingalpha.com/news/2942776-nimble-storage-minus-36_3-percent-on-fq3-miss-soft-guidance-pure-storage-minus-2_3-percent\" target=\"_blank\">weak FQ4 guidance</a>. Shares closed at $10.05, making new post-IPO lows along the way.</li>\n<li>\n<a href=\"http://blogs.barrons.com/techtraderdaily/2015/11/20/nimble-plunges-47-is-a-take-out-next/?mod=BOLBlog\" target=\"_blank\">Those downgrading</a> generally cited some mixture of competitive concerns, sales execution questions, and delayed profitability as the hybrid storage array vendor ramps investments in the face of slower-than-expected growth. Some also made the case a turnaround will take several quarters.</li>\n<li>UBS' Steve Milunovich: \"Nimble\u2019s problems are both self- and market-made ... It turned out that booking business in the enterprise has been more difficult than expected. A contributor to that difficulty is the lack of storage market growth and increasing competitiveness as EMC, NetApp, and others fight for fewer deals. The result for Nimble is some combination of (1) elongated sales cycles, (2) lost deals (the company claims no change in enterprise win rate), or (3) lower pricing (discounts did affect the product margin).\"</li>\n<li>Raymond James' Brian Alexander: \"We suspect public cloud migration is accelerating, and this is causing storage incumbents to become more aggressive in protecting their installed base, and Nimble cannot seem to pry customers away with its hybrid offering. All-flash arrays are likely going to have a larger impact as well, as flash price declines narrow the price/performance gap previously enjoyed by Nimble.\"</li>\n<li>William Blair's Jason Ader: \"Nimble\u2019s hybrid story has quickly aged against the all\u2010flash and hyperconverged trends sweeping the industry, providing daylight for exceedingly aggressive newcomers with little regard for profit margins. On the [SMB] side, while management insists that win\u2010rates are unchanged and reinvestment will solve the issues, we cannot help but worry that aggressive startups are leaping to take advantage of the opportunity. On top of all of this, the public cloud looms as an ever\u2010present, undiscriminating threat to on\u2010 premise storage in general.\"</li>\n<li>BMO's Keith Bachman is keeping an Outperform rating, even as he admits his original thesis was off. \"We had previously assumed (incorrectly) that Nimble\u2019s technology advantage would enable the company to take share in both the midmarket and enterprise, while also gradually growing profits and cash flows. However, we think the challenges of Nimble\u2019s competitors are now engulfing Nimble, in terms of both revenue growth and profits.\" He thinks Nimble's planned entrance into the all-flash array could help, but isn't assuming a big contribution for now.</li>\n<li>However, Bachman also argues Nimble, whose market cap now stands at $783M, could make a compelling buyout target, particularly given a buyer could eliminate much of the company's non-R&amp;D spend. \"The incumbent storage vendors are seeking growth and could meaningfully improve Nimble\u2019s sales leverage ... Nimble\u2019s gross margins remain 67%, which would be accretive to Nimble\u2019s competitors.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2945236\" data-linked=\"Nimble slammed with 11 downgrades due to earnings/guidance; shares close down 50.7%\" data-tweet=\"$NMBL - Nimble slammed with 11 downgrades due to earnings/guidance; shares close down 50.7% https://seekingalpha.com/news/2945236-nimble-slammed-11-downgrades-due-to-earnings-guidance-shares-close-down-50_7?source=tweet\" data-url=\"https://seekingalpha.com/news/2945236-nimble-slammed-11-downgrades-due-to-earnings-guidance-shares-close-down-50_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2945176\" data-ts=\"1448054026\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2945176-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li> <b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EWZ' title='iShares MSCI Brazil Capped ETF'>EWZ</a> <font color='green'>+9.77%</font>. <a href='https://seekingalpha.com/symbol/EWA' title='iShares MSCI Australia ETF'>EWA</a> <font color='green'>+6.84%</font>. <a href='https://seekingalpha.com/symbol/BRF' title='Market Vectors Brazil Small-Cap ETF'>BRF</a> <font color='green'>+6.67%</font>. <a href='https://seekingalpha.com/symbol/ILF' title='iShares Latin America 40 ETF'>ILF</a> <font color='green'>+6.37%</font>. <a href='https://seekingalpha.com/symbol/EEM' title='iShares MSCI Emerging Markets ETF'>EEM</a> <font color='green'>+4.8%</font>.  </li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a> <font color='red'>-12.67%</font>. <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='red'>-11.47%</font>. <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a> <font color='red'>-9.75%</font>. <a href='https://seekingalpha.com/symbol/FCG' title='First Trust ISE-Revere Natural Gas Index ETF'>FCG</a> <font color='red'>-4.69%</font>. <a href='https://seekingalpha.com/symbol/GDXJ' title='Market Vectors Junior Gold Miners ETF'>GDXJ</a> <font color='red'>-2.39%</font>. &nbsp; </li> </ul><div class=\"tiny-share-widget\" data-id=\"2945176\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$EWZ $EWA $BRF - Weekly ETF Gainers / Losers https://seekingalpha.com/news/2945176-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2945176-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2945086\" data-ts=\"1448052849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2945086-wsjs-jakab-4t-cf-in-nat-gas-storage-to-terrify-energy-investors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ&#39;s Jakab: 4T cf in nat gas storage ought to &quot;terrify&quot; energy investors</a></h4><ul>     <li>U.S. natural gas in storage cracked the 4T cf level for the first time, according to the <a href=\"https://seekingalpha.com/news/2941306-natural-gas-inventory-builds\" target=\"_blank\">latest data</a> from the Energy Information Administration, 10% higher than a year ago and nearly as much gas as the U.S. can store - a milestone that \"<a href=\"http://www.wsj.com/articles/bulging-natural-gas-storage-should-terrify-energy-investors-1448045820\" target=\"_blank\">should terrify energy investors</a>,\" writes Heard On The Street's Spencer Jakab.</li>     <li>Inventories traditionally peak at the end of the April-October season when heating demand for the fuel is low or nonexistent, but despite subdued new drilling activity, the EIA thinks storage at the end of Q1 2016 will end with a far higher than usual 1.9T cf, which creates a risk of storage filling up even sooner in next year's April-October period.</li>     <li>Jakab says the situation will add to the woes among beleaguered natural gas producers, some of which are in financial distress - which could grow more acute; in related news, Chesapeake Energy (<a href=\"https://seekingalpha.com/symbol/CHK\" title=\"Chesapeake Energy Corporation\">CHK</a> <font color=\"red\">-5.6%</font>) is down another 5% today, recording new multiyear lows.</li>     <li>ETFs: <a href=\"https://seekingalpha.com/symbol/UNG\" title=\"The United States Natural Gas ETF, LP\">UNG</a>, <a href=\"https://seekingalpha.com/symbol/UGAZ\" title=\"VelocityShares 3x Long Natural Gas ETN\">UGAZ</a>, <a href=\"https://seekingalpha.com/symbol/DGAZ\" title=\"VelocityShares 3x Inverse Natural Gas ETN\">DGAZ</a>, <a href=\"https://seekingalpha.com/symbol/BOIL\" title=\"ProShares Ultra Bloomberg Natural Gas ETF\">BOIL</a>, <a href=\"https://seekingalpha.com/symbol/GAZ-OLD\" title=\"iPath DJ-UBS Natural Gas Total Return Sub-Index ETN\">GAZ-OLD</a>, <a href=\"https://seekingalpha.com/symbol/FCG\" title=\"First Trust Natural Gas ETF\">FCG</a>, <a href=\"https://seekingalpha.com/symbol/GASL\" title=\"Direxion Daily Natural Gas Related Bull 3x Shares ETF\">GASL</a>, <a href=\"https://seekingalpha.com/symbol/KOLD\" title=\"ProShares UltraShort Bloomberg Natural Gas ETF\">KOLD</a>, <a href=\"https://seekingalpha.com/symbol/UNL\" title=\"The United States 12 Month Natural Gas ETF, LP\">UNL</a>, <a href=\"https://seekingalpha.com/symbol/DCNG\" title=\"iPath Pure Beta Seasonal Natural Gas ETN\">DCNG</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"2945086\" data-linked=\"WSJ&#39;s Jakab: 4T cf in nat gas storage ought to &quot;terrify&quot; energy investors\" data-tweet=\"$CHK $CHK $UNG - WSJ&#39;s Jakab: 4T cf in nat gas storage ought to &quot;terrify&quot; energy investors https://seekingalpha.com/news/2945086-wsjs-jakab-4t-cf-in-nat-gas-storage-to-terrify-energy-investors?source=tweet\" data-url=\"https://seekingalpha.com/news/2945086-wsjs-jakab-4t-cf-in-nat-gas-storage-to-terrify-energy-investors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944996\" data-ts=\"1448049682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944996-chipotle-sinks-after-new-e-coli-cases-reported\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipotle sinks after new E. coli cases reported</a></h4><ul> <li>Chipotle (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>) dives after the CDC <a href=\"http://www.cdc.gov/ecoli/2015/O26-11-15/index.html\" target=\"_blank\">reports</a> on more E. coli cases linked to the restaurant chain.</li> <li>The agency says 45 people across six different states have been infected. California, Minnesota, New York, and Ohio have been added to the original list of states with an outbreak.</li> <li>CMG <font color='red'>-8.87%</font> to $557.27.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"2944996\" data-linked=\"Chipotle sinks after new E. coli cases reported\" data-tweet=\"$CMG - Chipotle sinks after new E. coli cases reported https://seekingalpha.com/news/2944996-chipotle-sinks-after-new-e-coli-cases-reported?source=tweet\" data-url=\"https://seekingalpha.com/news/2944996-chipotle-sinks-after-new-e-coli-cases-reported\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>85&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944946\" data-ts=\"1448049117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944946-yelp-up-10_1-on-strong-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp up 10.1% on strong volume</a></h4><ul><li><a href='https://seekingalpha.com/symbol/YELP' title='Yelp'>YELP</a> has topped $30 for the first time since July without any major news crossing the wires. 4.7M shares have been traded, well above a 3-month daily average of 2.9M.</li><li>The online local reviews leader. Shares <a href=\"https://seekingalpha.com/news/2921906-yelp-up-2_5-percent-after-iac-offers-to-buy-angies-list\" target=\"_blank\">rallied last week</a> after IAC's bid for Angie's List fueled hopes Yelp would also get an offer, and added to their gains on an <a href=\"https://seekingalpha.com/news/2928556-yelp-on-the-move-as-sell-sider-steps-in\" target=\"_blank\">RBC upgrade</a>. They're <font color='green'>up 23%</font> since the IAC offer was disclosed, but still <font color='red'>down 44%</font> YTD.</li></ul><div class=\"tiny-share-widget\" data-id=\"2944946\" data-linked=\"Yelp up 10.1% on strong volume\" data-tweet=\"$YELP - Yelp up 10.1% on strong volume https://seekingalpha.com/news/2944946-yelp-up-10_1-on-strong-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/2944946-yelp-up-10_1-on-strong-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944886\" data-ts=\"1448045183\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/W\" target=\"_blank\">W</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944886-wayfairplus-3_2-director-buys-shares-amid-tilson-driven-selloff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wayfair +3.2%; director buys shares amid Tilson-driven selloff</a></h4><ul>\n<li>Bob Gamgort <a href=\"http://www.insidermonkey.com/insider-trading/filing/5372258\" target=\"_blank\">has disclosed</a> he bought 7K Wayfair (NYSE:<a href=\"https://seekingalpha.com/symbol/W\" title=\"Wayfair\">W</a>) shares on Tuesday at prices of $35.90, $36.00, and $36.50.</li>\n<li>The purchases came as the online furniture retailer sold off after Whitney Tilson <a href=\"https://seekingalpha.com/news/2933286-tilson-pitches-spirit-airlines-long-wayfair-short-at-robin-hood\" target=\"_blank\">reiterated</a> his <a href=\"https://seekingalpha.com/news/2774746-wayfair-closes-down-6_5-percent-after-tilson-discloses-hes-also-short\" target=\"_blank\">bearish stance</a> at the Robin Hood Investor's Conference.</li>\n<li>Shares are <font color=\"green\">up 84%</font> YTD, but <font color=\"red\">down 36%</font> from an August peak of $56.84.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2944886\" data-linked=\"Wayfair +3.2%; director buys shares amid Tilson-driven selloff\" data-tweet=\"$W - Wayfair +3.2%; director buys shares amid Tilson-driven selloff https://seekingalpha.com/news/2944886-wayfairplus-3_2-director-buys-shares-amid-tilson-driven-selloff?source=tweet\" data-url=\"https://seekingalpha.com/news/2944886-wayfairplus-3_2-director-buys-shares-amid-tilson-driven-selloff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944826\" data-ts=\"1448042953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IO\" target=\"_blank\">IO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944826-ion-now-up-52-on-week-insider-buys-continue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ion now up 52% on the week; insider buys continue</a></h4><ul><li><a href=\"https://seekingalpha.com/news/2939636-ion-rallies-amid-flurry-of-insider-buys\" target=\"_blank\">Nine insider buys</a> have been disclosed this week for beaten-down Ion Geophysical (<a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a> <font color='green'>+11.2%</font>). The most recent buys include a 750K-share purchase by director James Lapeyre at $0.43, a 50K-share purchase by CEO Brian Hanson at $0.40, and purchases of 26K and 4K shares by general counsel James Seely at $0.34 and $0.33.</li><li>Director Franklin Myers and CFO Steven Bate <a href=\"https://seekingalpha.com/news/2939636-ion-rallies-amid-flurry-of-insider-buys\" target=\"_blank\">have also</a> recently bought shares. The seismic hardware/services firm sports an $82M market cap, and has fallen over 95% since 2011.</li><li><a href=\"https://seekingalpha.com/news/2902096-ion-up-61_2-percent-after-q3-beat-25m-buyback\" target=\"_blank\">Two weeks ago:</a> Ion jumps on Q3 beat, $25M buyback</li></ul><div class=\"tiny-share-widget\" data-id=\"2944826\" data-linked=\"Ion now up 52% on the week; insider buys continue\" data-tweet=\"$IO - Ion now up 52% on the week; insider buys continue https://seekingalpha.com/news/2944826-ion-now-up-52-on-week-insider-buys-continue?source=tweet\" data-url=\"https://seekingalpha.com/news/2944826-ion-now-up-52-on-week-insider-buys-continue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944756\" data-ts=\"1448041644\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944756-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> KBIO <font color='green'>+80%</font>. MCUR <font color='green'>+79%</font>. <a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/LBMH' title='Liberator Medical Holdings, Inc.'>LBMH</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/GBIM' title='GlobeImmune'>OTC:GBIM</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/BONT' title='The Bon-Ton Stores, Inc.'>OTC:BONT</a> <font color='green'>+17%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NMBL' title='Nimble Storage, Inc.'>NMBL</a> <font color='red'>-50%</font>. <a href='https://seekingalpha.com/symbol/MENT' title='Mentor Graphics Corporation'>MENT</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/CRMT' title='America&#39;s Car-Mart, Inc.'>CRMT</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/NM' title='Navios Maritime Holdings Inc.'>NM</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage'>PSTG</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/RYI' title='Ryerson Holding Corp.'>RYI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='red'>-11%</font>. STV <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/RCPI' title='Rock Creek Pharmaceuticals, Inc.'>OTC:RCPI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2944756\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$HGEN $LPTX $SRPT - Midday Gainers / Losers https://seekingalpha.com/news/2944756-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2944756-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944746\" data-ts=\"1448041404\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CF\" target=\"_blank\">CF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944746-new-irs-inversion-rules-bad-news-for-cf-industries-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New IRS inversion rules bad news for CF Industries, analyst says</a></h4><ul>     <li>New IRS rules aiming to reduce the number of corporate inversions <a href=\"http://blogs.barrons.com/stockstowatchtoday/2015/11/20/new-irs-rules-are-bad-news-for-cf-industries-citi/?mod=BOL_hp_blog_stw\" target=\"_blank\">could be bad news</a> for CF Industries (<a href=\"https://seekingalpha.com/symbol/CF\" title=\"CF Industries Holdings, Inc.\">CF</a> <font color=\"red\">-4.2%</font>) and its <a href=\"https://seekingalpha.com/news/2701366-cf-industries-oci-announce-nitrogen-mega-merger\" target=\"_blank\">proposed acquisition</a> of $8B in assets from OCI, Citigroup analyst P.J. Juvekar warns.</li>     <li>CF planned to change its tax domicile to the U.K. from the U.S. as part of the transaction, which the company said could reduce its tax rate substantially from the current ~35%; Juvekar thinks the rule which limits a third country of domicile could be an impediment, as CF is based in the U.S., OCI is based in the Netherlands, and the new company post-merger would be based in the U.K.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2944746\" data-linked=\"New IRS inversion rules bad news for CF Industries, analyst says\" data-tweet=\"$CF - New IRS inversion rules bad news for CF Industries, analyst says https://seekingalpha.com/news/2944746-new-irs-inversion-rules-bad-news-for-cf-industries-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/2944746-new-irs-inversion-rules-bad-news-for-cf-industries-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944736\" data-ts=\"1448041305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944736-ambarella-rises-5_2-on-healthy-volume-outperforms-gopro\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ambarella rises 5.2% on healthy volume, outperforms GoPro</a></h4><ul>\n<li>Ambarella (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMBA\" title=\"Ambarella\">AMBA</a>) has rallied strongly on a day the Nasdaq is up 0.6%. 2.74M shares have been traded; the 3-month daily average is 2.97M.</li>\n<li>On the week, Amabrella is <font color=\"green\">up 15%</font>. The gains come even though top client GoPro (while up 2.5% today) is down 4% on the week after getting hammered on Wednesday due to a <a href=\"https://seekingalpha.com/news/2937496-gopro-minus-3_9-percent-piper-cuts-target-to-15-reports-of-camera-discounts\" target=\"_blank\">bearish Piper note</a> raising pricing/margin concerns. Ambarella, which also sells to GoPro's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GPRO\" title=\"GoPro\">GPRO</a>) rivals and services various non-action camera markets, rose modestly on Wednesday in spite of GoPro's fall.</li>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/Canaccord+Genuity+Remains+Bullish+on+Beaten+Down+Ambarella+%28AMBA%29/11077100.html\" target=\"_blank\">Canaccord defended</a> the video processor developer on Monday following a talk with CTO Les Kohn. Kohn argued rival solutions from app processor vendors such as Qualcomm, Intel, and Nvidia can't match Ambarella's offerings in terms of compression and power efficiency, and claimed 3x advantages for both memory bandwidth and power needs for H.264 video compression. Qualcomm (NASDAQ:<a href=\"https://seekingalpha.com/symbol/QCOM\" title=\"Qualcomm Inc.\">QCOM</a>) <a href=\"https://seekingalpha.com/news/2775786-qualcomm-launches-snapdragon-flight-drone-platform-challenges-ambarella\" target=\"_blank\">has tried to differentiate</a> its drone offerings in part by providing system-level reference architectures; the company also <a href=\"https://www.qualcomm.com/news/releases/2015/10/26/qualcomm-announces-ip-camera-reference-platform-high-end-processing-imaging\" target=\"_blank\">recently unveiled</a> an IP video camera reference platform.</li>\n<li>Ambarella's FQ3 results are due on Dec. 3. 12.4M shares (43% of the float) were shorted as of Oct. 30.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2944736\" data-linked=\"Ambarella rises 5.2% on healthy volume, outperforms GoPro\" data-tweet=\"$AMBA $AMBA $GPRO - Ambarella rises 5.2% on healthy volume, outperforms GoPro https://seekingalpha.com/news/2944736-ambarella-rises-5_2-on-healthy-volume-outperforms-gopro?source=tweet\" data-url=\"https://seekingalpha.com/news/2944736-ambarella-rises-5_2-on-healthy-volume-outperforms-gopro\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944596\" data-ts=\"1448039844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMUC\" target=\"_blank\">IMUC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944596-immunocellulars-lead-product-candidate-barely-beats-placebo-in-mid-stage-study-subgroup-of\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoCellular&#39;s lead product candidate barely beats placebo in mid-stage study; subgroup of patients targeted for Phase 3; shares down 13%</a></h4><ul>\n<li>Nano cap ImmunoCellular Therapeutics (<a href=\"https://seekingalpha.com/symbol/IMUC\" title=\"ImmunoCellular Therapeutics, Ltd.\">OTCPK:IMUC</a> <font color=\"red\">-13.3%</font>) slumps on triple normal volume in response to its announcement of results from a mid-stage study of lead product candidate ICT-107 in patients with brain cancer (glioblastoma). The data are being presented at the 20th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology in San Antonio, TX.</li>\n<li>In the 124-patient intent-to-treat population, median overall survival (OS) in patients receiving<a href=\"http://www.imuc.com/pipeline/ict-107\" target=\"_blank\"> ICT-107</a> was only 10% better than placebo and fell short of statistical significance.</li>\n<li>In a pre-specified subgroup, those seropositive for <a href=\"https://en.wikipedia.org/wiki/HLA-A*02\" target=\"_blank\">HLA-A2 </a>(human leukocyte antigen alpha 2), which helps the immune system detect and attack cancer cells, the positive effect from ICT-107 was more profound. In a group categorized as MGMT methylated, those receiving ICT-107 experienced median OS of 13.8 months or 58% better than placebo. In MGMT unmethylated subjects, median OS was 4.0 months or 34% better than placebo. MGMT methylation is associated with improved response to radiation and chemotherapy. Neither difference achieved statistical significance, though, because they were not powered to do so.</li>\n<li>In HLA-A2+ patients, 60% of those in the ICT-107 cohort showed a statistically significant immune response versus 36% for placebo (an immune response is associated with survival). In addition, those treated with ICT-107 experienced a statistically valid survival benefit (p=0.0084). Immune response was similar in the MGMT methylated and unmethylated groups.</li>\n<li>Based on these data, the company's <a href=\"https://clinicaltrials.gov/ct2/show/NCT02546102?term=ict-107&amp;rank=2\" target=\"_blank\">Phase 3</a> design will target HLA-A2+ patients, both MGMT methylated and unmethylated. The randomized, double-blind, 400-subject, placebo-controlled trial will commence shortly. The primary endpoint will be OS. According to clinicaltrials.gov, the estimated final data collection date for the primary endpoint is December 2019. The estimated study completion date is December 2021.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2944596\" data-linked=\"ImmunoCellular&#39;s lead product candidate barely beats placebo in mid-stage study; subgroup of patients targeted for Phase 3; shares down 13%\" data-tweet=\"$IMUC - ImmunoCellular&#39;s lead product candidate barely beats placebo in mid-stage study; subgroup of patients targeted for Phase 3; shares down 13% https://seekingalpha.com/news/2944596-immunocellulars-lead-product-candidate-barely-beats-placebo-in-mid-stage-study-subgroup-of?source=tweet\" data-url=\"https://seekingalpha.com/news/2944596-immunocellulars-lead-product-candidate-barely-beats-placebo-in-mid-stage-study-subgroup-of\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944716\" data-ts=\"1448039712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVG\" target=\"_blank\">AVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944716-avg-up-6_1-after-goldman-conference-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AVG up 6.1% after Goldman conference talk</a></h4><ul>\n<li>\n<a href=\"https://seekingalpha.com/symbol/AVG\" title=\"AVG Technologies\">AVG</a> is rallying a day after the PC/mobile security software and services provider presented at a Goldman conference. 265K shares have been traded vs. a 3-month daily average of 451K.</li>\n<li>Share rose on Wednesday after <a href=\"https://seekingalpha.com/news/2937626-avg-issues-soft-2016-guidance\" target=\"_blank\">AVG issued</a> below-consensus 2016 sales guidance. A fair amount of <a href=\"https://seekingalpha.com/news/2897376-avg-down-12_8-percent-on-q3-miss-soft-guidance-cfo-change-planned\" target=\"_blank\">bad news</a> was already priced in.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2944716\" data-linked=\"AVG up 6.1% after Goldman conference talk\" data-tweet=\"$AVG - AVG up 6.1% after Goldman conference talk https://seekingalpha.com/news/2944716-avg-up-6_1-after-goldman-conference-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/2944716-avg-up-6_1-after-goldman-conference-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944706\" data-ts=\"1448039699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTU\" target=\"_blank\">BTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944706-peabody-energy-cloud-peak-energy-cut-to-sell-ubs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peabody Energy, Cloud Peak Energy cut to Sell at UBS</a></h4><ul>     <li>Peabody Energy (<a href=\"https://seekingalpha.com/symbol/BTU\" title=\"Peabody Energy Corp.\">BTU</a> <font color=\"red\">-4.8%</font>) and Cloud Peak Energy (<a href=\"https://seekingalpha.com/symbol/CLD\" title=\"Cloud Peak Energy, Inc.\">CLD</a> <font color=\"red\">-5.1%</font>) are <a href=\"http://blogs.barrons.com/stockstowatchtoday/2015/11/20/coal-it-gets-worse/\" target=\"_blank\">downgraded to Sell</a> at UBS, which says U.S. coal prices remain \"cornered by market and regulatory forces.\"</li>     <li>UBS says it sees the U.S. coal space remaining in a prolonged state of oversupply, with limited cost reduction potential left in the U.S. coal production base.</li>     <li>\"Any recovery in gas prices may come too late for the highly levered U.S. coal players, and even those with healthier balance sheets are having damage progressively inflicted as higher price legacy multi-year contracts roll off, cash burn continues, and utilities reduce forward coal purchases,\" UBS says.</li>     <li>The firm maintains its Sell rating on Arch Coal (<a href=\"https://seekingalpha.com/symbol/ACI\" title=\"Albertsons Companies Inc\">ACI</a> <font color=\"red\">-6.4%</font>) and cuts its stock price target by 67% to $0.50; it also cuts targets for BTU by 82% to $6, CLD by 55% to $2.50, and Consol Energy (<a href=\"https://seekingalpha.com/symbol/CNX\" title=\"CNX Resources Corporation\">CNX</a> <font color=\"red\">-0.7%</font>) by 10% to $9 with a Neutral rating.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2944706\" data-linked=\"Peabody Energy, Cloud Peak Energy cut to Sell at UBS\" data-tweet=\"$BTU $BTU $CLDPQ - Peabody Energy, Cloud Peak Energy cut to Sell at UBS https://seekingalpha.com/news/2944706-peabody-energy-cloud-peak-energy-cut-to-sell-ubs?source=tweet\" data-url=\"https://seekingalpha.com/news/2944706-peabody-energy-cloud-peak-energy-cut-to-sell-ubs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944696\" data-ts=\"1448039578\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944696-tesla-motors-falls-after-model-s-seat-belt-recall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla Motors falls after Model S seat belt recall</a></h4><ul> <li>Tesla Motors (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) <a href=\"http://www.bloomberg.com/news/articles/2015-11-20/tesla-conducts-voluntary-recall-of-90-000-model-s-sedans\" target=\"_blank\">issues</a> a recall of 90K Model S vehicles, according to media reports.</li> <li>The recall action is due to the risk that front seat belts could malfunction.</li> <li>All Model S vehicles on the road are included in the recall.</li> <li>TSLA <font color='red'>-1.71%</font> after sitting in positive territory.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2944696\" data-linked=\"Tesla Motors falls after Model S seat belt recall\" data-tweet=\"$TSLA - Tesla Motors falls after Model S seat belt recall https://seekingalpha.com/news/2944696-tesla-motors-falls-after-model-s-seat-belt-recall?source=tweet\" data-url=\"https://seekingalpha.com/news/2944696-tesla-motors-falls-after-model-s-seat-belt-recall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>437&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944686\" data-ts=\"1448039449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KUTV\" target=\"_blank\">KUTV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944686-ku6-mediaminus-1_7-q3-earnings-show-another-revenue-jump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ku6 Media -1.7%; Q3 earnings show another revenue jump</a></h4><ul>   <li>Ku6 Media (NASDAQ:<a href=\"https://seekingalpha.com/symbol/KUTV\" title=\"Ku6 Media Co., Ltd.\">KUTV</a>) is <font color=\"red\">off 1.7%</font> after a <a href=\"https://seekingalpha.com/news/2943446-ku6-media-reports-q3-results\" target=\"_blank\">Q3 report</a> where revenues again jumped Y/Y and sequentially and net loss narrowed somewhat.</li>    <li>The company gets most of its revenue from a single ad agency agreement with Huzhong Advertising; this summer it had entered into a supplemental agreement to increase the price charged to Huzhong, which expires Dec. 31, 2017.</li>    <li>Higher rates and volume from its ad partner led to revenues that increased 2.9% from Q2 and 51.8% Y/Y.</li>    <li>As of Sept. 30, it had $7.91M in cash and equivalents, up from $4.38M at year-end 2014 mainly due to a $4.84M loan from Xudong Xu which was assumed by major shareholder Shanda Interactive.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"2944686\" data-linked=\"Ku6 Media -1.7%; Q3 earnings show another revenue jump\" data-tweet=\"$KUTV - Ku6 Media -1.7%; Q3 earnings show another revenue jump https://seekingalpha.com/news/2944686-ku6-mediaminus-1_7-q3-earnings-show-another-revenue-jump?source=tweet\" data-url=\"https://seekingalpha.com/news/2944686-ku6-mediaminus-1_7-q3-earnings-show-another-revenue-jump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944656\" data-ts=\"1448038814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLTH\" target=\"_blank\">DLTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944656-solid-gains-for-duluth-holdings-in-opening-trades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solid gains for Duluth Holdings in opening trades</a></h4><ul> <li>Duluth Holdings (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DLTH\" title=\"Duluth Holdings\">DLTH</a>) opened trading at $13 after the company priced its IPO at $12 earlier today.</li> <li>Shares have peaked at $14.39 so far amid a broad rally in retail.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/2816526-duluth-trading-files-for-ipo\" target=\"_blank\">Duluth Holdings files for IPO</a> (Oct. 07 2015)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2944126-duluth-holdings-prices-ipo-below-range\" target=\"_blank\">Duluth Holdings prices IPO below range</a> (Nov. 20 2015)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"2944656\" data-linked=\"Solid gains for Duluth Holdings in opening trades\" data-tweet=\"$DLTH - Solid gains for Duluth Holdings in opening trades https://seekingalpha.com/news/2944656-solid-gains-for-duluth-holdings-in-opening-trades?source=tweet\" data-url=\"https://seekingalpha.com/news/2944656-solid-gains-for-duluth-holdings-in-opening-trades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944606\" data-ts=\"1448038040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICON\" target=\"_blank\">ICON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944606-retail-stocks-stage-broad-recovery\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail stocks stage broad recovery</a></h4><ul> <li>The S&amp;P Retail ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>) is <font color='green'>up 1.9%</font> with apparel and footwear stocks doing much of the heavy lifting.</li> <li>A vibrant rally in sports stocks was sparked by earnings reports and Nike. Iconix Brand (<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a> <font color='green'>+2.5%</font>), G-III Apparel (<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, LTD.'>GIII</a> <font color='green'>+3%</font>), DSW (<a href='https://seekingalpha.com/symbol/DSW' title='DSW Inc.'>DSW</a> <font color='green'>+3.7%</font>), Finish Line (<a href='https://seekingalpha.com/symbol/FINL' title='The Finish Line, Inc.'>FINL</a> <font color='green'>+3.1%</font>), Caleres (<a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a> <font color='green'>+2.2%</font>), Genesco (<a href='https://seekingalpha.com/symbol/GCO' title='Genesco Inc.'>GCO</a> <font color='green'>+3.5%</font>), and Shoe Carnival (<a href='https://seekingalpha.com/symbol/SCVL' title='Shoe Carnival, Inc.'>SCVL</a> <font color='green'>+1.7%</font>) join the <a href=\"https://seekingalpha.com/news/2944326-the-game-is-back-on-for-sports-stocks\" target=\"_blank\">list</a> reported on earlier.</li> <li>Luxury names are on the move with Kate Spade (<a href='https://seekingalpha.com/symbol/KATE' title='Kate Spade & Company'>KATE</a> <font color='green'>+2%</font>), Fossil (<a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='green'>+2.9%</font>), Coach (COH <font color='green'>+1.4%</font>), and Movado (<a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a> <font color='green'>+2.7%</font>) higher.</li> <li>The beat-up mall retailer group is also recovering after results from Gap (<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='green'>+6%</font>) and Abercrombie &amp; Fitch (<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a> <font color='green'>+19.4%</font>) topped worst-case scenarios. American Eagle Outfitters (<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='green'>+2.3%</font>), Guess (<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='green'>+4.6%</font>), and Pacific Sunwear (<a href='https://seekingalpha.com/symbol/PSUN' title='Pacific Sunwear of California, Inc.'>PSUN</a> <font color='green'>+5.4%</font>) are notable gainers.</li> <li>Big box retailers are the laggards today. Wal-Mart, Target (<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color='green'>+0.6%</font>), and Costco (<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a> <font color='green'>+0.6%</font>) are right at market index averages.</li></ul><div class=\"tiny-share-widget\" data-id=\"2944606\" data-linked=\"Retail stocks stage broad recovery\" data-tweet=\"$ICON $XRT $ICON - Retail stocks stage broad recovery https://seekingalpha.com/news/2944606-retail-stocks-stage-broad-recovery?source=tweet\" data-url=\"https://seekingalpha.com/news/2944606-retail-stocks-stage-broad-recovery\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944576\" data-ts=\"1448036851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UVE\" target=\"_blank\">UVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944576-universal-insurance-makes-case-stock-continues-to-tumble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Universal Insurance makes its case as stock continues to tumble</a></h4><ul>\n<li>\"Universal Insurance (<a href=\"https://seekingalpha.com/symbol/UVE\" title=\"Universal Insurance Holdings, Inc\">UVE</a> <font color=\"red\">-10.8%</font>) understands the Florida market,\" says the company, as it attempts to rebut - point by point - the short sale case made this week by Anthony Bozza.</li>\n<li>As for Bozza's claim that a Cat 4 hurricane would blow the company up, Universal says it's \"patently false, irresponsible, and defamatory.\"</li>\n<li>\"No single hurricane event in recorded history is projected to cause losses exceeding the limits of our 2015 reinsurance program ... UVE would remain profitable even if Florida were to face three storms in one season on the scale of Hurricane Andrew.\"</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2943006-under-attack-universal-insurance-launches-10m-buyback\" target=\"_blank\">Under attack, Universal Insurance launches $10M buyback</a> (Nov. 19)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2944576\" data-linked=\"Universal Insurance makes its case as stock continues to tumble\" data-tweet=\"$UVE - Universal Insurance makes its case as stock continues to tumble https://seekingalpha.com/news/2944576-universal-insurance-makes-case-stock-continues-to-tumble?source=tweet\" data-url=\"https://seekingalpha.com/news/2944576-universal-insurance-makes-case-stock-continues-to-tumble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944516\" data-ts=\"1448035965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQ\" target=\"_blank\">SQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944516-square-match-add-to-gains-on-day-two-dorsey-holds-court\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Square, Match add to gains on day two; Dorsey holds court</a></h4><ul>\n<li>Square (<a href=\"https://seekingalpha.com/symbol/SQ\" title=\"Square, Inc.\">SQ</a> <font color=\"green\">+3.3%</font>) is now <font color=\"green\">up 50%</font> from its conservative $9 IPO price, and worth close to $5.5B after factoring employee options. Match Group (<a href=\"https://seekingalpha.com/symbol/MTCH\" title=\"Match Group, Inc.\">MTCH</a> <font color=\"green\">+8.2%</font>) is <font color=\"green\">up 33%</font> from its $12 IPO price, and worth $3.8B.</li>\n<li>Square/Twitter CEO Jack Dorsey made the rounds yesterday. <a href=\"http://www.cnbc.com/2015/11/19/cnbc-exclusive-cnbc-transcript-square-founder-ceo-jack-dorsey-on-cnbcs-squawk-on-the-street-today.html\" target=\"_blank\">On CNBC</a>, he talked up Square's efforts to expand internationally (the company still depends heavily on the U.S.), as well as a <a href=\"https://squareup.com/contactless-chip-reader\" target=\"_blank\">new mobile card reader</a> that supports Apple Pay and EMV (chip-based) card transactions. \"We's selling it at $49. We have seen 350,000 pre-orders already ... We want to associate that Square shape with 'you can pay with your phone.'\"</li>\n<li>He also argued Square has the potential to reach a chunk of the small businesses (20M in the U.S., 85M globally) that currently don't accept credit cards, and noted his company has advanced over $300M to 40K sellers via its Square Capital service. In <a href=\"http://recode.net/2015/11/19/jack-dorsey-still-wants-to-resurrect-square-wallet/\" target=\"_blank\">a talk with Re/code</a>, Dorsey suggested he wants to resurrect (perhaps through the <a href=\"https://play.google.com/store/apps/details?id=com.squareup.cash&amp;hl=en\" target=\"_blank\">Square Cash</a> app) Square Wallet, which allowed users to order from stores in advance through a mobile app, and pay by simply saying their name at the register.</li>\n<li>Meanwhile, Match chairman Greg Blatt <a href=\"http://www.cnbc.com/2015/11/19/match-chairman-tinder-ceo-story-unfortunate.html\" target=\"_blank\">has further distanced</a> his company from a less-than-flattering <a href=\"http://www.standard.co.uk/lifestyle/london-life/tinder-im-an-addict-says-hookup-apps-cocreator-and-ceo-sean-rad-a3117181.html\" target=\"_blank\">interview</a> of Tinder CEO Sean Rad. \"It's a silly and unfortunate article. I think there are a lot of inaccuracies there and a lot of things taken out of context, and I actually think there's some corrections being made,\"</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/SQ/news\" target=\"_blank\">Prior Square coverage</a>. <a href=\"https://seekingalpha.com/symbol/MTCH/news\" target=\"_blank\">Prior Match coverage</a>\n</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/SQ/focus\" target=\"_blank\">Square IPO analysis</a>. <a href=\"https://seekingalpha.com/symbol/MTCH/focus\" target=\"_blank\">Match IPO analysis</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2944516\" data-linked=\"Square, Match add to gains on day two; Dorsey holds court\" data-tweet=\"$SQ $SQ $MTCH - Square, Match add to gains on day two; Dorsey holds court https://seekingalpha.com/news/2944516-square-match-add-to-gains-on-day-two-dorsey-holds-court?source=tweet\" data-url=\"https://seekingalpha.com/news/2944516-square-match-add-to-gains-on-day-two-dorsey-holds-court\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944436\" data-ts=\"1448034111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFI\" target=\"_blank\">GFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944436-fed-hike-knock-gold-price-down-to-1000-oz-gold-fields-ceo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fed hike could knock gold price down to $1,000/oz., Gold Fields CEO says</a></h4><ul>     <li>A Fed interest rate hike in December could <a href=\"http://www.miningweekly.com/article/fed-hike-could-knock-gold-price-down-to-1-000oz-gold-fields-2015-11-19\" target=\"_blank\">knock back the price of gold to ~$1,000/oz.</a>, Gold Fields (<a href=\"https://seekingalpha.com/symbol/GFI\" title=\"Gold Fields Limited\">GFI</a> <font color=\"red\">-3.1%</font>) CEO Nick Holland tells Creamer Media after the company's share price <a href=\"https://seekingalpha.com/news/2941146-gold-fields-surges-as-south-deep-costs-fall\" target=\"_blank\">soared 29%</a> in Johannesburg for its best single day of trading since 1999.</li>     <li>The uncertainty around a rate increase has played havoc with the gold price in recent weeks, but Holland says long-term fundamentals for gold remain positive, based on projections of inadequate supply; \u201cIt doesn\u2019t matter what we do now as an industry, a supply fall-off is inevitable,\" the CEO says.</li>     <li>\"Is it three years of  pain, four years, five years? We  don\u2019t know, but we\u2019re in a long-term business and we can\u2019t take  decisions for one year,\u201d Holland said after GFI reported improved <a href=\"https://seekingalpha.com/news/2939896-gold-fields-reports-q3-results\" target=\"_blank\">Q3 earnings</a> and higher net cash flow to cut net debt to 1.4x EBITDA.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/GLD\" title=\"SPDR Gold Trust ETF\">GLD</a>, <a href=\"https://seekingalpha.com/symbol/IAU\" title=\"iShares Gold Trust ETF\">IAU</a>, <a href=\"https://seekingalpha.com/symbol/PHYS\" title=\"Sprott Physical Gold Trust\">PHYS</a>, <a href=\"https://seekingalpha.com/symbol/SGOL\" title=\"Aberdn Std Gold Shs\">SGOL</a>, <a href=\"https://seekingalpha.com/symbol/UGL\" title=\"ProShares Ultra Gold ETF\">UGL</a>, <a href=\"https://seekingalpha.com/symbol/DGP\" title=\"DB Gold Double Long ETN\">DGP</a>, <a href=\"https://seekingalpha.com/symbol/GTU\" title=\"Central Gold-Trust\">GTU</a>, <a href=\"https://seekingalpha.com/symbol/GLL\" title=\"ProShares UltraShort Gold ETF\">GLL</a>, <a href=\"https://seekingalpha.com/symbol/UGLD\" title=\"VelocityShares 3x Long Gold ETN\">UGLD</a>, <a href=\"https://seekingalpha.com/symbol/DZZ\" title=\"DB Gold Double Short ETN\">DZZ</a>, <a href=\"https://seekingalpha.com/symbol/OUNZ\" title=\"VanEck Merk Gold Trust ETF\">OUNZ</a>, <a href=\"https://seekingalpha.com/symbol/DGL\" title=\"Inv DB Mul-Sec Shs Invesco DB Gold Fund\">DGL</a>, <a href=\"https://seekingalpha.com/symbol/DGZ\" title=\"DB Gold Short ETN\">DGZ</a>, <a href=\"https://seekingalpha.com/symbol/DGLD\" title=\"VelocityShares 3x Inverse Gold ETN\">DGLD</a>, <a href=\"https://seekingalpha.com/symbol/AGOL\" title=\"ETFS Physical Asian Gold Shares Trust ETF\">AGOL</a>, <a href=\"https://seekingalpha.com/symbol/UBG\" title=\"UBS ETRACS CMCI Gold Total Return ETN\">UBG</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2944436\" data-linked=\"Fed hike could knock gold price down to $1,000/oz., Gold Fields CEO says\" data-tweet=\"$GFI $GFI $GLD - Fed hike could knock gold price down to $1,000/oz., Gold Fields CEO says https://seekingalpha.com/news/2944436-fed-hike-knock-gold-price-down-to-1000-oz-gold-fields-ceo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/2944436-fed-hike-knock-gold-price-down-to-1000-oz-gold-fields-ceo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944406\" data-ts=\"1448033832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUNEQ\" target=\"_blank\">SUNEQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944406-jpmorgan-sunedison-can-avoid-bankruptcy-price\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan: SunEdison can avoid bankruptcy ... at a price</a></h4><ul>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+SunEdison+%28SUNE%29+Rating+Cut+to+Neutral+at+JPMorgan+as+Situation+Seen+as+Risky%3B+Firm+Can+Avoid+Bankruptcy%2C+Says+Analyst/11095306.html\" target=\"_blank\">JPMorgan's Paul Coster:</a> \"We think SUNE is still able to escape the ongoing liquidity crisis, but at a high cost owing to M&amp;A over-commitment, reduced cash flow from the YieldCos, increased use of high-cost financing options and the negative impact this has on DevCo revenue-growth and margins relative to our prior expectations.\" He has downgraded the beleaguered solar/wind project developer to Neutral, and cut his target by $14 to $5.</li>\n<li>While Coster thinks SunEdison (SUNE <font color=\"red\">-5.4%</font>) can avoid bankruptcy, he argues risks still remain related to the <a href=\"https://seekingalpha.com/news/2637765-sunedison-to-buy-vivint-solar-in-2_2b-deal\" target=\"_blank\">Vivint Solar</a> and <a href=\"https://seekingalpha.com/news/2145205-sunedison-forms-1gw-brazilian-solar-jv\" target=\"_blank\">Renova</a> deals, along with \"the need to execute a pivot to DevCo cash sales at decent margin against the backdrop of distractions.\" He has cut his annualized shipment and gross margin estimates, and significantly lowered dividend growth rate estimates for the TerraForm Power and TerraForm Global YieldCos.</li>\n<li>Coster: \"We think the stock is somewhat undervalued, the firm\u2019s development and operational assets are high quality, but the situation is complicated, fluid and risky, so we move to the sidelines, deeply disappointed that we did not do so ahead of the 'death-spiral' ... By our calculation, SUNE remains liquid through 2016-2019, positioned to roll over debt in 2020.\"</li>\n<li>Shares are lower once more, and now <font color=\"red\">down 63%</font> from where they traded before SunEdison's Nov. 10 Q3 report.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/2637765-sunedison-to-buy-vivint-solar-in-2_2b-deal\" target=\"_blank\">Two days ago:</a> Deutsche defends SunEdison after talking with management</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2944406\" data-linked=\"JPMorgan: SunEdison can avoid bankruptcy ... at a price\" data-tweet=\"$SUNEQ - JPMorgan: SunEdison can avoid bankruptcy . at a price https://seekingalpha.com/news/2944406-jpmorgan-sunedison-can-avoid-bankruptcy-price?source=tweet\" data-url=\"https://seekingalpha.com/news/2944406-jpmorgan-sunedison-can-avoid-bankruptcy-price\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944376\" data-ts=\"1448033072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRMT\" target=\"_blank\">CRMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944376-americas-car-mart-slides-after-bottom-line-falls-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">America&#39;s Car Mart slides after bottom line falls short</a></h4><ul> <li>America's Car-Mart (<a href=\"https://seekingalpha.com/symbol/CRMT\" title=\"America's Car-Mart, Inc.\">CRMT</a> <font color=\"red\">-20.7%</font>) slumps after a painful FQ2 EPS miss.</li> <li>The company says margin rates took a hit due in part to higher repair costs.</li> <li>The provision for credit losses was 32.4% of sales vs. 26.3% a year ago. SG&amp;A expenses as a percentage of sales were also higher.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2943266-americas-car-mart-misses-by-0_41-misses-on-revenue\" target=\"_blank\">America's Car-Mart misses by $0.41, misses on revenue</a> (Nov. 19 2015)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"2944376\" data-linked=\"America&#39;s Car Mart slides after bottom line falls short\" data-tweet=\"$CRMT - America&#39;s Car Mart slides after bottom line falls short https://seekingalpha.com/news/2944376-americas-car-mart-slides-after-bottom-line-falls-short?source=tweet\" data-url=\"https://seekingalpha.com/news/2944376-americas-car-mart-slides-after-bottom-line-falls-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944366\" data-ts=\"1448032790\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VMEM\" target=\"_blank\">VMEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944366-violin-memory-down-5_6-following-nimble-storages-earnings-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Violin Memory down 5.6% following Nimble Storage&#39;s earnings/guidance</a></h4><ul>\n<li>Violin Memory (NYSE:<a href=\"https://seekingalpha.com/symbol/VMEM\" title=\"Violin Memory, Inc.\">VMEM</a>) has joined Pure Storage (previously covered) in selling off after Nimble Storage (<font color=\"red\">down 46.7%</font>) <a href=\"https://seekingalpha.com/news/2942326-nimble-storage-misses-by-0_06-misses-on-revenue\" target=\"_blank\">missed</a> FQ3 (October quarter) estimates and provided <a href=\"https://seekingalpha.com/news/2942776-nimble-storage-minus-36_3-percent-on-fq3-miss-soft-guidance-pure-storage-minus-2_3-percent\" target=\"_blank\">weak FQ4 guidance</a>.</li>\n<li>Like Pure, Violin differs from Nimble (a hybrid flash/disk array vendor that depends heavily on SMB sales) in that it's an all-flash array provider that focuses heavily on enterprise clients. Nimble blamed its numbers on slower-than-expected traction for its efforts to grow enterprise sales, and the impact of its shift from commercial (SMB) to enterprise investments on the former business.</li>\n<li>The selloff comes ahead of Violin's Dec. 2 FQ3 report. Shares <font color=\"red\">-75%</font> YTD.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2944366\" data-linked=\"Violin Memory down 5.6% following Nimble Storage&#39;s earnings/guidance\" data-tweet=\"$VMEM - Violin Memory down 5.6% following Nimble Storage&#39;s earnings/guidance https://seekingalpha.com/news/2944366-violin-memory-down-5_6-following-nimble-storages-earnings-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/2944366-violin-memory-down-5_6-following-nimble-storages-earnings-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944326\" data-ts=\"1448032189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FL\" target=\"_blank\">FL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944326-game-is-back-on-for-sports-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The game is back on for sports stocks</a></h4><ul> <li>Strong earning reports from Foot Locker (<a href=\"https://seekingalpha.com/symbol/FL\" title=\"Foot Locker, Inc.\">FL</a> <font color=\"green\">+7.9%</font>), Hibbett Sports (<a href=\"https://seekingalpha.com/symbol/HIBB\" title=\"Hibbett Sports, Inc.\">HIBB</a> <font color=\"green\">+4.7%</font>), Sportsman's Warehouse Holdings (<a href=\"https://seekingalpha.com/symbol/SPWH\" title=\"Sportsman's Warehouse Holdings, Inc.\">SPWH</a> <font color=\"green\">+19.6%</font>) seem to be reverberating around the sportswear/footwear sector.</li> <li>Lululemon (<a href=\"https://seekingalpha.com/symbol/LULU\" title=\"Lululemon Athletica Inc.\">LULU</a> <font color=\"green\">+5.3%</font>), Big Five Sporting Goods (<a href=\"https://seekingalpha.com/symbol/BGFV\" title=\"Big 5 Sporting Goods Corporation\">BGFV</a> <font color=\"green\">+2.4%</font>), Skechers (<a href=\"https://seekingalpha.com/symbol/SKX\" title=\"Skechers USA Inc.\">SKX</a> <font color=\"green\">+4.4%</font>), Columbia Sportswear (<a href=\"https://seekingalpha.com/symbol/COLM\" title=\"Columbia Sportswear Company\">COLM</a> <font color=\"green\">+4.1%</font>), Under Armour (<a href=\"https://seekingalpha.com/symbol/UA\" title=\"Under Armour, Inc. Class C\">UA</a> <font color=\"green\">+3.6%</font>), V.F. Corp (<a href=\"https://seekingalpha.com/symbol/VFC\" title=\"V.F. Corporation\">VFC</a> <font color=\"green\">+1.7%</font>), Steven Madden (<a href=\"https://seekingalpha.com/symbol/SHOO\" title=\"Steven Madden, Ltd.\">SHOO</a> <font color=\"green\">+3.5%</font>), Crocs (<a href=\"https://seekingalpha.com/symbol/CROX\" title=\"Crocs, Inc.\">CROX</a> <font color=\"green\">+2.2%</font>), and Wolverine Worldwide (<a href=\"https://seekingalpha.com/symbol/WWW\" title=\"Wolverine World Wide Inc.\">WWW</a> <font color=\"green\">+3.3%</font>) are all solidly higher.</li> <li>Cabela's (<a href=\"https://seekingalpha.com/symbol/CAB\" title=\"Cabela's Incorporated\">CAB</a> <font color=\"green\">+7.2%</font>) is higher off more <a href=\"https://seekingalpha.com/news/2943116-bloomberg-bass-pro-shops-might-bid-for-cabelas\" target=\"_blank\">merger speculation</a>, while Nike (<a href=\"https://seekingalpha.com/symbol/NKE\" title=\"Nike Inc.\">NKE</a> <font color=\"green\">+5%</font>) gave investors plenty of <a href=\"https://seekingalpha.com/news/2943716-nike-plus-4-percent-after-string-of-good-news\" target=\"_blank\">reasons</a> to smile last night on the buybacks and dividend front.</li> <li>Dick's Sporting Goods (<a href=\"https://seekingalpha.com/symbol/DKS\" title=\"Dick's Sporting Goods, Inc.\">DKS</a> <font color=\"red\">-0.2%</font>) hasn't joined the sportswear party quite yet as the company's large retail footprint continues to dampen enthusiasm.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2944326\" data-linked=\"The game is back on for sports stocks\" data-tweet=\"$FL $FL $HIBB - The game is back on for sports stocks https://seekingalpha.com/news/2944326-game-is-back-on-for-sports-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/2944326-game-is-back-on-for-sports-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944316\" data-ts=\"1448032093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRMB\" target=\"_blank\">TRMB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944316-trimbleplus-3_3-goldman-upgrades-cites-distribution-efforts-and-cost-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trimble +3.3%; Goldman upgrades, cites distribution efforts and cost cuts</a></h4><ul>\n<li>Goldman's Jerry Revich <a href=\"http://www.theflyonthewall.com/permalinks/entry.php?symbol=TRMB\" target=\"_blank\">has upgraded</a> Trimble (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TRMB\" title=\"Trimble, Inc.\">TRMB</a>) to Buy, while keeping his $26 target. He cites the positioning/navigation hardware firm's efforts to cut costs and extend its <a href=\"http://buildings.trimble.com/industry-solutions\" target=\"_blank\">BuildingPoint </a>construction product distribution network.</li>\n<li>Trimble soared in late October after <a href=\"https://seekingalpha.com/news/2875076-trimble-navigation-beats-by-0_07-beats-on-revenue\" target=\"_blank\">beating</a> Q3 estimates and <a href=\"https://seekingalpha.com/news/2879076-trimble-up-17_6-percent-after-q3-beat-buybacks-lift-eps\" target=\"_blank\">issuing</a> better-than-feared Q4 guidance. Shares go for 18x a 2016 EPS consensus of $1.27.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2944316\" data-linked=\"Trimble +3.3%; Goldman upgrades, cites distribution efforts and cost cuts\" data-tweet=\"$TRMB - Trimble +3.3%; Goldman upgrades, cites distribution efforts and cost cuts https://seekingalpha.com/news/2944316-trimbleplus-3_3-goldman-upgrades-cites-distribution-efforts-and-cost-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/2944316-trimbleplus-3_3-goldman-upgrades-cites-distribution-efforts-and-cost-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944216\" data-ts=\"1448030722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIPS\" target=\"_blank\">VIPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944216-vipshop-up-4_5-after-tiger-global-discloses-10-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vipshop up 4.5% after Tiger Global discloses 10% stake</a></h4><ul>\n<li>In a <a href=\"http://www.sec.gov/Archives/edgar/data/1167483/000091957415008329/d6904745_sc13g.htm\" target=\"_blank\">13G filing</a>, Chase Coleman's Tiger Global discloses it now has a 9.9M-share (9.96%) stake in Vipshop (NYSE:<a href=\"https://seekingalpha.com/symbol/VIPS\" title=\"Vipshop Holdings\">VIPS</a>). As of Q1 2014, Tiger <a href=\"http://finance.yahoo.com/news/must-know-why-tiger-global-210015214.html\" target=\"_blank\">had a 4.54% stake</a>.</li>\n<li>The disclosure comes a week after the Chinese online retailer nosedived in response to a <a href=\"https://seekingalpha.com/news/2928646-vipshop-pre-announces-soft-q3-sales-shares-minus-26_6-percent\" target=\"_blank\">Q3 warning</a>. Shares recovered some of their losses on Wednesday after Vipshop <a href=\"https://seekingalpha.com/news/2936206-vipshops-q4-guidance-better-than-feared-shares-rise\" target=\"_blank\">posted Q3 results</a> and provided better-than-feared Q4 guidance. The company also reported (in spite of the sales shortfall) operating expenses fell to 20.7% of revenue from 23.3% a year ago.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2944216\" data-linked=\"Vipshop up 4.5% after Tiger Global discloses 10% stake\" data-tweet=\"$VIPS - Vipshop up 4.5% after Tiger Global discloses 10% stake https://seekingalpha.com/news/2944216-vipshop-up-4_5-after-tiger-global-discloses-10-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/2944216-vipshop-up-4_5-after-tiger-global-discloses-10-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944146\" data-ts=\"1448029646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADSK\" target=\"_blank\">ADSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944146-autodesk-down-3_7-on-soft-sales-outlook-subscription-billings-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Autodesk down 3.7% on soft sales outlook, subscription/billings guidance cut</a></h4><ul>\n<li>Though Autodesk (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ADSK\" title=\"Autodesk, Inc.\">ADSK</a>) beat FQ3 estimates, it's guiding for FQ4 revenue of $620M-$640M, below a $641M consensus. EPS guidance of $0.08-$0.12 is in-line with a $0.10 consensus.</li>\n<li>Also: FY16 (ends Jan. '16) net subscription add guidance has been cut to 310K-330K from 375K-425K, and FY16 billings growth guidance to 0.5%-1.5% from 2%-4%. Like Adobe and Microsoft, Autodesk has been <a href=\"https://seekingalpha.com/news/2762026-autodesk-plans-to-make-most-commercial-products-subscription-only\" target=\"_blank\">moving aggressively</a> to migrate license customers to subscriptions covering both on-premise and cloud software.</li>\n<li>\n<strong>Billings/subscriptions: </strong>Billings fell 9% Y/Y in FQ3 (-4% exc. forex), below revenue growth of -3% and a sharp reversal from FQ2's +7%; this was partly expected due to <a href=\"https://seekingalpha.com/news/2750256-autodesk-minus-6-percent-ah-as-q3-full-year-outlook-guided-lower-on-subscription-shift\" target=\"_blank\">the guidance given</a> with Autodesk's FQ2 report. Subscription adds totaled 80K, up from FQ2's 61K and bringing the base to 2.47M. That led the deferred revenue balance to rise 20% Y/Y to $1.21B. Subscriptions made up 53% of revenue.</li>\n<li>\n<strong>Financials: </strong>Boosting EPS: Non-GAAP operating expenses rose just $1.4M Y/Y to $468.5M. Also helping: $150M was spent to buy back 3.2M shares at an average price of $46.33. Autodesk ended FQ3 with $2.3B in cash, and $1.5B in long-term debt.</li>\n<li>In spite of the guidance cut, CEO Carl Bass strikes an optimistic tone: \"We are balancing the necessary investments in the transition with our ongoing focus on spend management, leading to better than expected profitability for [FQ3]. And we remain confident in our long-term view that our business model transition will deliver a 20 percent CAGR in subscriptions and a 24 percent CAGR in [annualized recurring revenue] through fiscal year 2020.\"</li>\n<li>On the earnings call (<a href=\"https://seekingalpha.com/article/3700786-autodesks-adsk-carl-bass-on-q3-2016-results-earnings-call-transcript?part=single\" target=\"_blank\">transcript</a>), Bass admitted Autodesk is seeing strong macro headwinds in \"most emerging markets.\" He also mentioned the company is exiting its creative finishing hardware business for media/entertainment firms. The exit is expected to have a $10M impact on FQ4 billings.</li>\n<li>Shares have dropped to $60.10 premarket.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/2942296-autodesk-beats-by-0_06-beats-on-revenue\" target=\"_blank\">FQ3 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2944146\" data-linked=\"Autodesk down 3.7% on soft sales outlook, subscription/billings guidance cut\" data-tweet=\"$ADSK - Autodesk down 3.7% on soft sales outlook, subscription/billings guidance cut https://seekingalpha.com/news/2944146-autodesk-down-3_7-on-soft-sales-outlook-subscription-billings-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/2944146-autodesk-down-3_7-on-soft-sales-outlook-subscription-billings-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944116\" data-ts=\"1448029020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944116-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> KBIO <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/LBMH' title='Liberator Medical Holdings, Inc.'>LBMH</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/INTU' title='Intuit Inc.'>INTU</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ROST' title='Ross Stores, Inc.'>ROST</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/OHRP' title='Ohr Pharmaceutical, Inc.'>OHRP</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/VIPS' title='Vipshop Holdings'>VIPS</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NMBL' title='Nimble Storage, Inc.'>NMBL</a> <font color='red'>-46%</font>. <a href='https://seekingalpha.com/symbol/MENT' title='Mentor Graphics Corporation'>MENT</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage'>PSTG</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WDAY' title='Workday'>WDAY</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/JMEI' title='Jumei International Holding Limited'>JMEI</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"2944116\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$HGEN $LBMH $SRPT - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/2944116-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/2944116-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2944106\" data-ts=\"1448028998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APTO\" target=\"_blank\">APTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2944106-aptose-bios-early-stage-study-of-lead-product-candidate-placed-on-clinical-hold-fda-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aptose Bio&#39;s early-stage study of lead product candidate placed on clinical hold by FDA; shares down 27% premarket</a></h4><ul>\n<li>Ultra-thinly traded nano cap Aptose Biosciences (NASDAQ:<a href=\"https://seekingalpha.com/symbol/APTO\" title=\"Aptose Biosciences Inc.\">APTO</a>) is down <font color=\"red\">27% </font>premarket, albeit on only 100 shares, in response to its announcement that its Phase 1b clinical trial assessing lead product candidate APTO-253 in patients with blood cancers has been placed on clinical hold by the FDA.</li>\n<li>The agency's action was prompted by operating problems with an IV infusion pump at a clinical trial site, specifically the occurrence of back pressure at the filter while a patient was being dosed. The move is intended to ensure patient safety and also to ensure that manufacturing and dosing procedures are consistent with documented quality standards.</li>\n<li>Aptose completed a safety review of all patient files prior to its discovery of manufacturing documentation irregularities. No drug-related serious adverse events have been reported and the observed pharmacokinetic levels in treated patients have been in the expected range.</li>\n<li>The specific length of the delay is unknown, but the trial should restart as soon as the issues are fully investigated.</li>\n<li>\n<a href=\"http://aptose.com/apto-253/\" target=\"_blank\">APTO-253</a> is a small molecule that has shown potent anti-tumor activity in cancer cells via its induction of a gene that expresses proteins called <a href=\"https://en.wikipedia.org/wiki/Kruppel-like_factors\" target=\"_blank\">Kruppel-like factors</a>, specifically KLF4. When the KLF4 gene is induced, it up-regulates expression of a protein called p21 which leads to cell cycle arrest and apoptosis (cell death).</li>\n<li>\n<strong>Update</strong>: On September 12, the company <a href=\"https://www.sec.gov/Archives/edgar/data/882361/000117184316012119/exh_991.htm\" target=\"_blank\">announced </a>that it submitted its formal responses to the FDA regarding the clinical hold.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2944106\" data-linked=\"Aptose Bio&#39;s early-stage study of lead product candidate placed on clinical hold by FDA; shares down 27% premarket\" data-tweet=\"$APTO - Aptose Bio&#39;s early-stage study of lead product candidate placed on clinical hold by FDA; shares down 27% premarket https://seekingalpha.com/news/2944106-aptose-bios-early-stage-study-of-lead-product-candidate-placed-on-clinical-hold-fda-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/2944106-aptose-bios-early-stage-study-of-lead-product-candidate-placed-on-clinical-hold-fda-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2943976\" data-ts=\"1448027664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMRN\" target=\"_blank\">BMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2943976-positive-ad-comm-vote-for-biomarins-drisapersen-in-doubt-shares-down-8-premarket-competitor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Positive Ad Comm vote for BioMarin&#39;s drisapersen in doubt; shares down 8% premarket; competitor Sarepta up 23%</a></h4><ul>\n<li>BioMarin Pharmaceutical's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BMRN\" title=\"BioMarin Pharmaceutical Inc.\">BMRN</a>) hoped-for endorsement of drisapersen for the treatment of Duchenne muscular dystrophy (DMD) on Tuesday by the FDA's Peripheral and Central Nervous System Drugs Advisory Committee looks dicey at this point. In <a href=\"http://www.thestreet.com/story/13373797/1/biomarin-duchenne-drug-receives-harsh-review-from-fda.html\" target=\"_blank\">information </a>posted on the FDA's site this morning, the panel's review of the efficacy data concluded that \"...while there may some evidence suggestive of efficacy of drisapersen, the evidence is inconsistent and in some cases contradictory, and does not reach the level of substantial evidence.\"</li>\n<li>Drisapersen may still pass muster, though, since the committee will hear two hours of testimony from DMD patients and their families.</li>\n<li>Shares are down <font color=\"red\">8%</font> premarket on robust volume. Competitor Sarepta Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a>) is up <font color=\"green\">23%</font> on heavy volume on rosier prospects for its DMD candidate, eteplirsen.</li>\n<li><a href=\"http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM473737.pdf\" target=\"_blank\">FDA briefing doc</a></li>\n<li><a href=\"http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM473738.pdf\" target=\"_blank\">BioMarin briefing doc</a></li>\n<li><a href=\"http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM473739.pdf\" target=\"_blank\">Addendum</a></li>\n<li><a href=\"http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM473740.pdf\" target=\"_blank\">Errata </a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2943976\" data-linked=\"Positive Ad Comm vote for BioMarin&#39;s drisapersen in doubt; shares down 8% premarket; competitor Sarepta up 23%\" data-tweet=\"$BMRN $BMRN $SRPT - Positive Ad Comm vote for BioMarin&#39;s drisapersen in doubt; shares down 8% premarket; competitor Sarepta up 23% https://seekingalpha.com/news/2943976-positive-ad-comm-vote-for-biomarins-drisapersen-in-doubt-shares-down-8-premarket-competitor?source=tweet\" data-url=\"https://seekingalpha.com/news/2943976-positive-ad-comm-vote-for-biomarins-drisapersen-in-doubt-shares-down-8-premarket-competitor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2943876\" data-ts=\"1448025141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANF\" target=\"_blank\">ANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2943876-abercrombie-fitch-pops-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abercrombie &amp; Fitch pops after earnings</a></h4><ul> <li>Abercrombie &amp; Fitch (NYSE:<a href=\"https://seekingalpha.com/symbol/ANF\" title=\"Abercrombie &amp; Fitch\">ANF</a>) reports comparable-store sales fell 1% in <a href=\"http://www.abercrombie.com/anf/investors/investorrelations.html\" target=\"_blank\">Q3</a>.</li> <li>A +3% comp for the Hollister brand helped to offset a 5% decline in the Abercrombie brand comp. The U.S. comp was down 3%, while the international comp was +1%.</li> <li>A&amp;F's gross profit rate improved 120 bps to 63.4% on lower store and distribution costs.</li> <li>Guidance: The company expects flat comparable-store sales growth in Q4. The gross margin rate is expected to be level with last year's mark.</li> <li>Shares of A&amp;F are <font color=\"green\">up 19.9%</font> to $23.35 to wipe away the 7.4% loss in the five sessions ahead of the earnings print. Short interest as always is a factor with the stock's wild swings.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2943876\" data-linked=\"Abercrombie &amp; Fitch pops after earnings\" data-tweet=\"$ANF - Abercrombie &amp; Fitch pops after earnings https://seekingalpha.com/news/2943876-abercrombie-fitch-pops-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/2943876-abercrombie-fitch-pops-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2943866\" data-ts=\"1448025059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAM\" target=\"_blank\">AKAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2943866-akamai-down-2_5-on-goldman-downgrade-to-sell-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akamai down 2.5% on Goldman downgrade to Sell (updated)</a></h4><ul>\n<li>Goldman has downgraded Akamai (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AKAM\" title=\"Akamai Technologies, Inc.\">AKAM</a>) to Sell, and cut its target by $10 to $52.</li>\n<li>The move comes less than a month after shares nosedived due to the <a href=\"https://seekingalpha.com/news/2863156-akamai-down-14-percent-on-soft-q4-guidance\" target=\"_blank\">soft Q4 guidance</a> (blamed on weakness at large media accounts) provided with a <a href=\"https://seekingalpha.com/news/2861676-akamai-beats-by-0_04-beats-on-revenue\" target=\"_blank\">Q3 beat</a>. SA author/streaming analyst <a href=\"https://seekingalpha.com/article/3613736-apple-microsoft-and-facebook-bring-more-traffic-to-in-house-cdns-impacting-akamais-media-business\" target=\"_blank\">Dan Rayburn</a> thinks the guidance is due to Apple, Microsoft, and Facebook moving more of their CDN traffic to in-house networks.</li>\n<li>Shares have fallen to $57.73 premarket. The 52-week low (set in February) is $56.85.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/2940986-akamai-strikes-cloud-cdn-interconnect-deal-with-google-shares-rise\" target=\"_blank\">Yesterday:</a> Akamai strikes cloud CDN interconnect deal with Google</li>\n<li>\n<strong>Update (10:39AM ET): </strong>More details <a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Goldman+Sachs+Downgrades+Akamai+Technologies+%28AKAM%29+to+Sell/11095197.html\" target=\"_blank\">here</a>. Goldman's Heather Bellini: \"We view Street forecasts for 2016 as too high, as media delivery revenues take longer to materially snap back due to (1) large customers slowly bringing CDN in-house, (2) re emergence of more aggressive competition and (3) a focus on reducing software download sizes. As such, we see these headwinds persisting for longer than consensus is expecting.\" Akamai is now <font color=\"red\">down 5.6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2943866\" data-linked=\"Akamai down 2.5% on Goldman downgrade to Sell (updated)\" data-tweet=\"$AKAM - Akamai down 2.5% on Goldman downgrade to Sell (updated) https://seekingalpha.com/news/2943866-akamai-down-2_5-on-goldman-downgrade-to-sell-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/2943866-akamai-down-2_5-on-goldman-downgrade-to-sell-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2943846\" data-ts=\"1448024926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HGEN\" target=\"_blank\">HGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2943846-martin-shkrelli-new-chief-of-kalobios-up-to-13m-in-funding-committed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Martin Shkrelli new chief of KaloBios; up to $13M in funding committed</a></h4><ul>\n<li>Nano cap KaloBios (KBIO) <a href=\"http://www.prnewswire.com/news-releases/kalobios-pharmaceuticals-inc-appoints-martin-shkreli-ceo-and-announces-new-financing-300182439.html\" target=\"_blank\">names </a>Martin Shkreli as Chairman &amp; CEO after his investor group acquired 70% of the company's outstanding shares. A $3M equity investment has been committed in addition to an equity financing facility of $10M, subject to shareholder approval (which should be a slam dunk).</li>\n<li>Students of the market have had the privilege of observing one of the most brutal short squeezes in history over the past four days. The stock bottomed at $0.44 on Monday morning after the company's announcement on Friday afternoon that it was shutting down. Mr. Shrkeli's group jumped in and the stock skyrocketed, peaking at $14.72 yesterday.</li>\n<li>KaloBios will operate independently from Mr. Shkreli's Turing Pharmaceuticals AG.</li>\n<li>Shares are up <font color=\"green\">19%</font> premarket on increased volume.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2939716-kalobios-rockets-818-percent-as-shkreli-buys-up-control-mulls-keeping-firm-alive\" target=\"_blank\">KaloBios rockets 818% as Shkreli buys up control, mulls keeping firm alive</a> (Nov. 18)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2930206-kalobios-minus-47-percent-as-it-says-its-shutting-down\" target=\"_blank\">KaloBios -47% as it says it's shutting down</a> (Nov. 13)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2943846\" data-linked=\"Martin Shkrelli new chief of KaloBios; up to $13M in funding committed\" data-tweet=\"$HGEN - Martin Shkrelli new chief of KaloBios; up to $13M in funding committed https://seekingalpha.com/news/2943846-martin-shkrelli-new-chief-of-kalobios-up-to-13m-in-funding-committed?source=tweet\" data-url=\"https://seekingalpha.com/news/2943846-martin-shkrelli-new-chief-of-kalobios-up-to-13m-in-funding-committed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2943836\" data-ts=\"1448024829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANF\" target=\"_blank\">ANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2943836-abercrombie-and-amp-fitch-beats-0_26-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abercrombie &amp;amp; Fitch beats by $0.26, beats on revenue</a></h4><ul>\n<li>Abercrombie &amp; Fitch (NYSE:<a href=\"https://seekingalpha.com/symbol/ANF\" title=\"Abercrombie &amp; Fitch\">ANF</a>): Q3 EPS of $0.48 <font color=\"green\">beats by $0.26</font>.</li>\n<li>Revenue of $878.57M (-3.6% Y/Y) <font color=\"green\">beats by $13.92M</font>.</li>\n<li>Shares <font color=\"green\">+19.61%</font> PM.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2943836\" data-linked=\"Abercrombie &amp;amp; Fitch beats by $0.26, beats on revenue\" data-tweet=\"$ANF - Abercrombie &amp; Fitch beats by $0.26, beats on revenue https://seekingalpha.com/news/2943836-abercrombie-and-amp-fitch-beats-0_26-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/2943836-abercrombie-and-amp-fitch-beats-0_26-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2943786\" data-ts=\"1448024429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2943786-sprint-investors-react-poorly-to-sale-leaseback-scheme\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint investors react poorly to sale-leaseback scheme</a></h4><ul>\n<li>Sprint (NYSE:<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a>) <font color=\"red\">-5%</font> premarket following <a href=\"http://investors.sprint.com/news--investor-events/newsroom/press-release-details/2015/Sprint-signs-12-billion-deal-for-the-sale-and-lease-back-of-certain-leased-devices-to-newly-formed-Mobile-Leasing-Solutions-LLC/default.aspx\" target=\"_blank\">the announcement</a> of $1.2B sale-leaseback plan.</li>\n<li>Under the plan, a group of investors including Sprint  (<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a>) majority owner Softbank (<a href=\"https://seekingalpha.com/symbol/SFTBF\" title=\"SoftBank Group\">OTCPK:SFTBF</a>, <a href=\"https://seekingalpha.com/symbol/SFTBY\" title=\"SoftBank Group ADR\">OTCPK:SFTBY</a>) will create a $1.2B into an entity to purchase the devices Sprint leases to customers.</li>\n<li>Sprint will then lease back the devices from the new  venture, giving it fresh funding \"at an attractive cost of capital which is  well below Sprint's alternatives in the high-yield debt market.\"</li>\n<li>\"Providing mobile devices to customers is the  biggest use of cash in the carrier model, and with this new structure we  have more closely aligned Sprint's cash flows with those associated  with leasing devices to our customers,\"  CFO  Tarek Robbiati says.</li>\n<li>The move will boost free cash flow, but reduce 2015 Ebitda by ~$400M.</li>\n<li>Related: <a href=\"https://seekingalpha.com/article/3562386-sprint-cost-cutting-is-a-sign-of-desperation\" target=\"_blank\">Sprint: Cost Cutting Is A Sign Of Desperation</a> (Oct. 9)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2943786\" data-linked=\"Sprint investors react poorly to sale-leaseback scheme\" data-tweet=\"$S $S $SFTBF - Sprint investors react poorly to sale-leaseback scheme https://seekingalpha.com/news/2943786-sprint-investors-react-poorly-to-sale-leaseback-scheme?source=tweet\" data-url=\"https://seekingalpha.com/news/2943786-sprint-investors-react-poorly-to-sale-leaseback-scheme\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2943756\" data-ts=\"1448023799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCR\" target=\"_blank\">BCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2943756-bard-takes-out-dme-distributor-for-181m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bard takes out DME distributor for $181M</a></h4><ul>\n<li>With the aim of enhancing its presence in the home care market, C.R. Bard (NYSE:<a href=\"https://seekingalpha.com/symbol/BCR\" title=\"C. R. Bard, Inc.\">BCR</a>) <a href=\"http://www.businesswire.com/news/home/20151120005341/en/Bard-Agrees-Acquire-Liberator-Medical\" target=\"_blank\">acquires </a>Liberator Medical Holdings (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/LBMH\" title=\"Liberator Medical Holdings, Inc.\">LBMH</a>), a direct-to-consumer distributor of Durable Medical Equipment (DME), for $3.35 per share (~$181M).</li>\n<li>Liberator sells general medical supplies including urological catheters, ostomy products, mastectomy fashions, diabetic supplies and a modest amount of Bard's products.</li>\n<li>The transaction, which will add ~$70M to Bard's top line and be slightly accretive to non-GAAP EPS in 2016, should close in Q1. Starting in 2017, the acquisition will add between five and ten cents to non-GAAP cash EPS.</li>\n<li>LBMH is up <font color=\"green\">25%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2943756\" data-linked=\"Bard takes out DME distributor for $181M\" data-tweet=\"$BCR $BCR $LBMH - Bard takes out DME distributor for $181M https://seekingalpha.com/news/2943756-bard-takes-out-dme-distributor-for-181m?source=tweet\" data-url=\"https://seekingalpha.com/news/2943756-bard-takes-out-dme-distributor-for-181m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2943716\" data-ts=\"1448023070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2943716-nikeplus-4-after-string-of-good-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike +4% after string of good news</a></h4><ul> <li>Shares of Nike (NYSE:<a href=\"https://seekingalpha.com/symbol/NKE\" title=\"Nike Inc.\">NKE</a>) ratchet higher in premarket action after the company launches a new buyback and boosts its dividend. A <a href=\"https://seekingalpha.com/news/2943606-strong-comp-growth-at-foot-locker-in-q3\" target=\"_blank\">strong earning report</a> from Foot Locker this morning should also add positively to sentiment.</li> <li>The company will split shares on December 24 which is expected to help prop up demand.</li> <li>Analysts see the Nike announcement as well-timed with broad concerns in retail starting to chip away at Nike's share price. The stock is still a favorite on Wall Street with the <a href=\"http://www.marketbeat.com/stocks/NYSE/NKE/\" target=\"_blank\">ratio</a> of bullish calls to bearish calls standing at 14 to 1.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2942646-nike-shares-the-spoils-with-new-buyback-plan-dividend-hike-and-stock-split\" target=\"_blank\">Nike shares the spoils with new buyback plan, dividend hike, and stock split</a> (Nov. 19 2015)</li> <li>NKE <font color=\"green\">+4.13%</font> premarket to $131.00</li> </ul><div class=\"tiny-share-widget\" data-id=\"2943716\" data-linked=\"Nike +4% after string of good news\" data-tweet=\"$NKE - Nike +4% after string of good news https://seekingalpha.com/news/2943716-nikeplus-4-after-string-of-good-news?source=tweet\" data-url=\"https://seekingalpha.com/news/2943716-nikeplus-4-after-string-of-good-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2943686\" data-ts=\"1448022841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2943686-stocks-set-for-higher-open\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks set for higher open</a></h4><ul>\n<li>Looking to finish a strong week with a strong session, traders have bid up U.S. stock index futures to their session high, with the DJIA <font color=\"green\">up 0.4%</font>, and Nasdaq 100 and S&amp;P 500 <font color=\"green\">up 0.25%</font>. A <font color=\"green\">4.15% premarket gain</font> for Nike after a dividend hike, buyback, and stock split is helping the Dow along.</li>\n<li>Europe is mixed, and Asia was modestly higher overnight.</li>\n<li>The 10-year Treasury yield is flat at 2.25%, gold is up $6 per ounce to $1,084, and oil is <font color=\"red\">lower by $0.56</font> per barrel to $40.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/SPY\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a>, <a href=\"https://seekingalpha.com/symbol/QQQ\" title=\"PowerShares QQQ Trust ETF\">QQQ</a>, <a href=\"https://seekingalpha.com/symbol/DIA\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a>, <a href=\"https://seekingalpha.com/symbol/SH\" title=\"ProShares Short S&amp;P 500 ETF\">SH</a>, <a href=\"https://seekingalpha.com/symbol/SSO\" title=\"ProShares Ultra S&amp;P 500 ETF\">SSO</a>, <a href=\"https://seekingalpha.com/symbol/SDS\" title=\"ProShares UltraShort S&amp;P 500 ETF\">SDS</a>, <a href=\"https://seekingalpha.com/symbol/VOO\" title=\"Vanguard S&amp;P 500 ETF\">VOO</a>, <a href=\"https://seekingalpha.com/symbol/IVV\" title=\"iShares Core S&amp;P 500 ETF\">IVV</a>, <a href=\"https://seekingalpha.com/symbol/UPRO\" title=\"ProShares UltraPro S&amp;P 500 ETF\">UPRO</a>, <a href=\"https://seekingalpha.com/symbol/PSQ\" title=\"ProShares Short QQQ ETF\">PSQ</a>, <a href=\"https://seekingalpha.com/symbol/SPXU\" title=\"ProShares UltraPro Short S&amp;P 500 ETF\">SPXU</a>, <a href=\"https://seekingalpha.com/symbol/TQQQ\" title=\"ProShares UltraPro QQQ ETF\">TQQQ</a>, <a href=\"https://seekingalpha.com/symbol/SPXL\" title=\"Direxion Daily S&amp;P 500 Bull 3x Shares ETF\">SPXL</a>, <a href=\"https://seekingalpha.com/symbol/RSP\" title=\"Guggenheim S&amp;P Equal Weight ETF\">RSP</a>, <a href=\"https://seekingalpha.com/symbol/SPXS\" title=\"Direxion Daily S&amp;P 500 Bear 3x Shares ETF\">SPXS</a>, <a href=\"https://seekingalpha.com/symbol/QID\" title=\"ProShares UltraShort QQQ ETF\">QID</a>, <a href=\"https://seekingalpha.com/symbol/SQQQ\" title=\"ProShares UltraPro Short QQQ ETF\">SQQQ</a>, <a href=\"https://seekingalpha.com/symbol/QLD\" title=\"ProShares Ultra QQQ ETF\">QLD</a>, <a href=\"https://seekingalpha.com/symbol/DOG\" title=\"ProShares Short Dow 30 ETF\">DOG</a>, <a href=\"https://seekingalpha.com/symbol/DXD\" title=\"ProShares UltraShort Dow30 ETF\">DXD</a>, <a href=\"https://seekingalpha.com/symbol/RWL\" title=\"RevenueShares Large Cap ETF\">RWL</a>, <a href=\"https://seekingalpha.com/symbol/UDOW\" title=\"ProShares UltraPro Dow 30 ETF\">UDOW</a>, <a href=\"https://seekingalpha.com/symbol/EPS\" title=\"WisdomTree Earnings 500 ETF\">EPS</a>, <a href=\"https://seekingalpha.com/symbol/SDOW\" title=\"ProShares UltraPro Short Dow 30 ETF\">SDOW</a>, <a href=\"https://seekingalpha.com/symbol/DDM\" title=\"ProShares Ultra Dow 30 ETF\">DDM</a>, <a href=\"https://seekingalpha.com/symbol/VFINX\" title=\"Vanguard 500 Index Fund Inv\">VFINX</a>, <a href=\"https://seekingalpha.com/symbol/BXUB\" title=\"Barclays Capital Long B Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUB</a>, <a href=\"https://seekingalpha.com/symbol/QQEW\" title=\"First Trust NASDAQ-100 Equal Weight Index ETF\">QQEW</a>, <a href=\"https://seekingalpha.com/symbol/QQQE\" title=\"Direxion NASDAQ-100 Equal Weighted Index Shares ETF\">QQQE</a>, <a href=\"https://seekingalpha.com/symbol/SPLX\" title=\"UBS ETRACS Monthly Reset 2xLeveraged S&amp;P 500 total Return ETN\">SPLX</a>, <a href=\"https://seekingalpha.com/symbol/SFLA\" title=\"iPath Long Extended 3x S&amp;P 500 Index TR Index ETN\">SFLA</a>, <a href=\"https://seekingalpha.com/symbol/BXUC\" title=\"Barclays Capital Long C Leveraged Exchange Traded Notes Linked to the S&amp;P 500® Total Return Index\">BXUC</a>, <a href=\"https://seekingalpha.com/symbol/QQXT\" title=\"First Trust Nasdaq-100 Ex-Tech Sector Index ETF\">QQXT</a>, <a href=\"https://seekingalpha.com/symbol/SPUU\" title=\"Direxion Daily S&amp;P 500 Bull 2x Shares ETF\">SPUU</a>, <a href=\"https://seekingalpha.com/symbol/LLSP\" title=\"Direxion Daily S&amp;P 500 Bull 1.25X Shares\">LLSP</a>, <a href=\"https://seekingalpha.com/symbol/UDPIX\" title=\"ProFunds Ultra Dow 30 ProFund Inv\">UDPIX</a>, <a href=\"https://seekingalpha.com/symbol/OTPIX\" title=\"ProFunds NASDAQ-100 Fund Inv\">OTPIX</a>, <a href=\"https://seekingalpha.com/symbol/RYARX\" title=\"Rydex Inverse S&amp;P 500® Strategy Fund A\">RYARX</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2943686\" data-linked=\"Stocks set for higher open\" data-tweet=\"$SPY $QQQ $DIA - Stocks set for higher open https://seekingalpha.com/news/2943686-stocks-set-for-higher-open?source=tweet\" data-url=\"https://seekingalpha.com/news/2943686-stocks-set-for-higher-open\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2943676\" data-ts=\"1448022440\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXLG\" target=\"_blank\">DXLG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2943676-on-destination-xl-groups-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Destination XL Group&#39;s Q3</a></h4><ul>     <li>Destination XL Group (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DXLG\" title=\"Destination XL Group, Inc.\">DXLG</a>) reports comparable-store sales rose 4.3 in Q3.</li>     <li>DXL retail stores comp grew 9.2% for the period.</li>     <li>Total transactions in DXL stores were up 5.8% Y/Y.</li>     <li>Gross margin rate increased 170 bps to 45%.</li>     <li>SG&amp;A expense rate improved 20 bps to 42.6%.</li>     <li>Inventories +5.47% to $133.31M.</li>     <li>Store count -7 Y/Y to 354.</li>     <li>\n<b>FY2015 Guidance</b>: Total sales: $438M to $440M; Total comp sales: ~+4% to +4.5%; Gross margin rate: ~45.9%; SG&amp;A: ~$180.5M; D&amp;A: ~$28.1M; Interest expense: ~3.4M; EBITDA: $21M to $22M; Operating margin rate: -1.7% to -1.2%; GAAP EPS:-$0.20 to -$0.23; Non-GAAP EPS: -$0.12 to -$0.14; Capex: $30M to $32M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2943676\" data-linked=\"More on Destination XL Group&#39;s Q3\" data-tweet=\"$DXLG - More on Destination XL Group&#39;s Q3 https://seekingalpha.com/news/2943676-on-destination-xl-groups-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/2943676-on-destination-xl-groups-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2943606\" data-ts=\"1448021147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FL\" target=\"_blank\">FL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2943606-strong-comp-growth-foot-locker-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Strong comp growth at Foot Locker in Q3</a></h4><ul>     <li>Foot Locker (NYSE:<a href=\"https://seekingalpha.com/symbol/FL\" title=\"Foot Locker, Inc.\">FL</a>) reports comparable-store sales rose 8.7% in Q3.</li>     <li>Total sales increased 8.9% excluding the impact of foreign currency fluctuations.</li>     <li>Gross margin rate grew 60 bps to 33.8%.</li>     <li>SG&amp;A expense rate improved 80 bps to 19.6%.</li>     <li>Merchandise inventories +0.91% $1.336B.</li>     <li>Store count -42 Y/Y to 3,432.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2943606\" data-linked=\"Strong comp growth at Foot Locker in Q3\" data-tweet=\"$FL - Strong comp growth at Foot Locker in Q3 https://seekingalpha.com/news/2943606-strong-comp-growth-foot-locker-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/2943606-strong-comp-growth-foot-locker-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2943516\" data-ts=\"1448019878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIBB\" target=\"_blank\">HIBB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2943516-on-hibbett-sports-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Hibbett Sports&#39; Q3</a></h4><ul>     <li>Hibbett Sports (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HIBB\" title=\"Hibbett Sports, Inc.\">HIBB</a>) reports comparable-store sales rose 0.6% in Q3.</li>     <li>Gross profit rate dropped 20 bps to 36.1%.</li>     <li>Store operating, selling, and administrative expenses rate decreased 100 bps to 21.1% mainly due to a favorable legal settlement.</li>     <li>Operating margin rate grew 80 bps to 13.1%.</li>     <li>Store count +62 Y/Y to 1,031.</li>     <li>\n<b>FY2016 Guidance</b>:Comparable-store sales: ~flat Y/Y; Diluted EPS: $2.87 to $2.94.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2943516\" data-linked=\"More on Hibbett Sports&#39; Q3\" data-tweet=\"$HIBB - More on Hibbett Sports&#39; Q3 https://seekingalpha.com/news/2943516-on-hibbett-sports-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/2943516-on-hibbett-sports-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:44 AM </div></div></li>","count":48,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}